Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports
Health Populi
MARCH 13, 2018
Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. The report pointed especially to hospital and pharmaceutical prices. As we know from the Trump Administration in power for the past fourteen months, we must keep our collective eye on this ball on a daily basis.
168 
Let's personalize your content